Skai X

Medical Equipment Manufacturing • Suwon, Gyeonggi-do 16419, Korea, Republic of • 1-10 Employees

Company overview

Headquarters	Suwon, Gyeonggi-do 16419, Korea, Republic of
Website	skaix.com
NAICS	3391
Keywords	Clinical Decision Support, Software As A Medical Device (Samd), Diabetic Retinopathy Detection, Ai-Powered Diagnostics, Age-Related Macular Degeneration (Amd) Detection, Cerebrovascular Aging (Cva) Metrics, Cloud & On-Prem Ai Apis, Deep-Learning Computer Vision, Fundus Imaging Analytics, Glaucoma & Optic-Nerve Analysis, Global Tortuosity Index (Gti), Medical Image Research & Patents, Population Health Screening, Precision Medicine Insights, Predictive Analytics For Chronic Disease, Regulatory-Grade Validation (Fda/Mdr/Mfds), Retinal Disease Screening, Stroke-Risk Analytics, Systemic Biomarker Prediction, Tele-Ophthalmology Solutions
Employees	1-10

Key Contact at Skai X

Hyunseung Choo 추현승

Chief Executive Officer

About Skai X

🧠 SKAI X Inc: Seeing the Future of Healthcare Through Your Eyes SKAI X is an AI-powered medical intelligence company revolutionizing diagnostics by turning eye scans into powerful predictors of systemic health. 🔍 What We Do: We combine multi-modal fundus imaging (CFI, UFI, OCT) with optimized AI models to: Detect 10+ eye diseases (DR, Glaucoma, AMD, etc.) with ~99% accuracy Predict 30+ biomarkers (e.g., glucose, cholesterol, BMI, BP) within ~5% clinical difference Assess stroke and cardiovascular risks using proprietary indicators like the Global Tortuosity Index (GTI) 💼 Our Products: SKAI Eyes: Real-time eye disease detection with heatmap-based explainability SKAI Biomarkers: One-shot prediction of systemic health from retinal scans SKAI Brains: Stroke and vascular risk stratification (R&D-backed with $2M grant) 🚀 Why Partner With Us? Clinically validated with top hospitals (Samsung Medical Center, Ajou University, SNUH) 95–99% diagnostic accuracy, 10% higher biomarker precision than traditional labs 📈 Backed by a Global Market Surge: $445M addressable Medical AI Eye segment 47% CAGR (2024–2027) PACS & imaging integration with Zeiss, Canon, Nidek, Optomed, and more 🧬 Our Edge: Multi-scale, multi-modal, and multi-task learning Textual symptom outputs, standardized RoIs, and AI heatmaps for interpretability Seamless deployment in clinical workflows with plug-and-play AI engines

Skai X revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$821,328
Total funding	No funding